A silver staining technique developed by Goodpasture and Bloom (1975) stains a specific protein associated with the activity of ribosomal cistrons during the preceding interphase. By counting the number of chromosomes with darkly stained nucleolus organizer regions (NORs), the number of active NORs
Computer-assisted image analysis of silver staining in normal and leukemic bone marrow
β Scribed by K. C. Arden; C. D. Bucana; D. A. Johnston; S. Pathak
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 488 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Computer-assisted image analysis was used to quantitate the amount of silver staining in interphase nuclei of bone marrow cells from acute lymphocytic leukemia (ALL) patients. When we compared the data obtained for the interphase nuclei with that obtained for the metaphare spreads, we found a strong correlation between the fraction of bone-marrow metaphases stained positively with silver, the average number of silver-positive nucleolus organizer regions per metaphase, and the amount of silver staining in the interphase nuclei. Computer-assisted image analysis of interphase nuclei can be used, therefore, to differentiate normal from ALL bone-marrow samples.
?o whom reprint requests should be sent, at Cellular Genetics Laboratory, Department of Cell Biology (173), M.D. Anderson Cancer Center,
π SIMILAR VOLUMES
Accurate quantification of disseminated tumor cells in hematological samples is of fundamental importance in clinical oncology. However, even highly standardized protocols allow only a rough estimation of the total analyzed cell number, as sample processing may have adverse effects on the number of
## Abstract Amyloidosis is a heterogeneous group of diseases with a common outcome: deposition of insoluble protein in the visceral organs and tissues. Primary amyloidosis is a consequence of different plasma cell disorders, and it is the most common form of amyloidosis in the United States with an
Evaluation of estrogen (ER) and progesterone (PR) receptor content is now an important procedure in the management of breast cancer patients. Production of monoclonal antibodies to ER and PR has permitted development of an enzyme immunoassay (EIA) and immunocytochemical assay (ICA). This study compa